ALKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alkami Technology Inc (ALKT) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong revenue growth and insider confidence, the technical indicators are bearish, and the stock lacks immediate upward momentum. Additionally, the recent analyst downgrades and disappointing guidance weigh on the stock's near-term potential. Holding off on a purchase until there is clearer evidence of a positive trend or improved guidance is recommended.
The technical indicators for ALKT are bearish. The MACD histogram is negative and expanding downward, RSI is neutral at 34.87, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 17.021, with key support at 15.868 and resistance at 18.175. This suggests limited upward momentum in the near term.
Insider buying: General Atlantic invested $60 million, and Director Joseph P. Payne invested $100,000, indicating confidence in the company's future.
Strong annual recurring revenue growth of 35% YoY, showcasing demand for its digital banking platform.
Partnerships with banks like Rhinebeck Bank and Clear Mountain Bank, enhancing customer experience and operational efficiency.
Disappointing 2026 revenue guidance, which came in below consensus, leading to multiple analyst downgrades.
SaaS multiple compression and slower Digital Sales and Service Platform deployments, which are extending time-to-revenue.
Bearish technical indicators and lack of immediate upward momentum.
In Q4 2025, Alkami reported revenue growth of 34.73% YoY to $120.79 million. Net income improved by 49.69% YoY but remained negative at -$11.44 million. EPS increased by 37.50% YoY to -$0.11. However, gross margin dropped by 5.38% YoY to 55.78%. While revenue growth is strong, profitability challenges persist.
Analyst sentiment is mixed but leaning negative in the near term. Multiple firms, including Lake Street, Barclays, and Goldman Sachs, lowered price targets due to disappointing guidance and SaaS multiple compression. However, some analysts, like Citizens and JPMorgan, maintain positive long-term views, citing healthy underlying business fundamentals and potential for margin improvement by 2030.
